BS Identity and Score for BEVESPI AEROSPHERE (AstraZeneca)

AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.

B
BS Level
Medical Devices, Pharma & Biotech
40.8 Avg BS

Based on 587 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: BEVESPI AEROSPHERE (AstraZeneca) (bevespi.com)

https://bevespi.com 📍 Industry: Medical Devices, Pharma & Biotech
26 BS / 100

BEVESPI AEROSPHERE is a high-substance, low-BS site that is heavily constrained by legal compliance. While it uses template-heavy patient resources and lacks modern structured data, the distance between what it claims and what it proves is narrow due to the inherent technical nature of pharmaceutical labeling.

Info Density Power-words vs. Substance ratio.
6
20% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
0
0% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
7
35% BS
Commodity Fingerprint Detection of industry clichés/templates.
5
33% BS
Identity & Authority Expert verifiability & Schema depth.
8
53% BS

Integrate Product and Organization schema with sameAs links to official FDA approval entries and AstraZeneca’s corporate identity. Replace the generic ‘clinical trials’ mentions with specific NCT (National Clinical Trial) identification numbers and direct links to the results. Add outbound links to peer-reviewed studies for the 5-minute onset claim to move from ‘claimed’ to ‘verified’ status. Remove the legacy star-rating technical flag if it is not supported by a transparent third-party review platform.

Info Density Power-words vs. Substance ratio.
6 Impact Weight: 30 / 100
20% BS

Information density is exceptionally high for a product site, though it suffers from extreme concept repetition necessitated by regulatory requirements. The H1 AIMS TO OPEN AIRWAYS TO THE MAX is the primary piece of marketing fluff, while H2 headings like A maintenance treatment for adults with COPD are purely functional. Body text provides granular technical data, such as the 5-minute onset claim and 24-week clinical trial durations. However, the requirement to state it is not a rescue inhaler across every page creates a high repetition-to-new-info ratio.

AI treats every internal link as a semantic statement — not a navigation hint. Validate your entity level link signals and confirm whether your anchors reinforce meaning or generate noise.

Semantic Coherence Homepage promise vs. Sub-page reality.
0 Impact Weight: 20 / 100
0% BS

There is zero semantic drift between the homepage and sub-pages. The homepage hero section defines the product as a long-term maintenance treatment, and sub-pages like copd-treatment.html and how-to-use-bevespi-inhaler.html deliver exactly on that promise with mechanical explanations and step-by-step physical protocols. The positioning of BEVESPI as a specific combination of LAMA and LABA medicines is consistent throughout the entire user journey.

Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.

Trust & Proof Verifiable evidence vs. Trust Theatre.
7 Impact Weight: 20 / 100
35% BS

The site exhibits minor trust theatre via a review_count of 1 on the How to Use page without a corresponding proof_links_count or verifiable user feedback system. While it references two 24-week clinical trials to support efficacy claims, it fails to provide direct outbound links to PubMed or ClinicalTrials.gov for the actual data. The trust_theatre_flag is true on page 2, suggesting the presence of unverifiable star ratings or testimonials.

The proof density is moderate; the ratio of verifiable technical specs (specific bronchodilator classes, dosage counts, and priming steps) to vague marketing claims is high. There are at least 8+ instances of specific evidence across the pages, including exact pricing ($35), trial durations (24 weeks), and physical inhaler components. The primary deficit is the lack of external validation links to verify the ‘greater than individual medicines alone’ claim.

To review a full competitive diagnostic applied to an enterprise level technical SEO agency, including a direct comparison against Dejan, examine the complete executive audit. View the iPullRank Executive SEO Strategy Dashboard for a practical example of how perception gaps, value prop drift, and audience misalignment are surfaced in real audits.

Commodity Fingerprint Detection of industry clichés/templates.
5 Impact Weight: 15 / 100
33% BS

The site follows a standard pharmaceutical ‘Brand.com’ template, matching industry clichés like clinical trial data, mechanism of action, and patient resources. The Breathing Room section is a classic value_prop_cliche (innovation for life/healthcare reimagined) that acts as a generic content hub for patient engagement. While the product itself is specific, the resource articles like 5 activities you can enjoy with kids or grandkids are highly commoditized content found across almost all COPD medication sites.

Identity & Authority Expert verifiability & Schema depth.
8 Impact Weight: 15 / 100
53% BS

A significant technical gap exists as schema_json is null across all four analyzed pages, missing Organization and Product structured data. While the brand AstraZeneca is identified, there is no Person schema for medical reviewers or experts, even when referencing Robert’s story or nurse contact lines. The technical implementation does not match the authoritative status of a global pharmaceutical entity, relying on brand recognition rather than structured digital proof.

The performance claims are bold, specifically the starting at 5 minutes improvement, but they are tempered by the mandatory individual results may vary disclaimer. Unlike typical B2B BS, these claims are likely backed by internal regulatory filings, but the lack of direct peer-reviewed citations in the text creates a disconnect for a scientific audience. The site demonstrates the product’s function through detailed instructional videos and text rather than just making vague assertions.

Medical Devices, Pharma & Biotech BS: BEVESPI AEROSPHERE (AstraZeneca) (bevespi.com)

BS: 26/ 100

The website perfectly aligns with the Pharma and Medical Device industry, focusing on a prescription bronchodilator for COPD. It adheres to strict regulatory communication standards, including prominent Important Safety Information (ISI) and specific chemical nomenclature like glycopyrrolate and formoterol fumarate.

AI does not interpret your layout visually — it interprets your structure mathematically. Explore the Semantic HTML Technical Framework to understand how heading logic, boundaries, and DOM depth determine what an LLM can retrieve.

“The score of 26 is driven primarily by technical authority gaps (missing schema) and trust theatre flags (unverifiable review count). The site lost points in information density due to the massive redundancy of regulatory warnings, but scored a perfect 0 in semantic coherence due to flawless messaging alignment. It remains well below the BS threshold for typical consumer-facing websites.”

Verified Analysis Date: May 29, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Get a Strategic Holistic View
FREE TOOLS
BUSINESS STRATEGY

Business Intelligence Engine

×
AI VISIBILITY